ROMERIO, ALESSIO
ROMERIO, ALESSIO
DIPARTIMENTO DI BIOTECNOLOGIE E BIOSCIENZE
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists
2025 Franco, A; Aladailleh, Z; Romerio, A; Italia, A; Lami, F; Shaik, M; Skupinska, N; Artusa, V; Pirianov, G; Peri, F
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists
2024 Lami, F; Romerio, A; Italia, A; Shaik, M; Martin-Santamaria, S; Peri, F
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant
2024 Shaik, M; Pasco, S; Romerio, A; Pifferi, C; Sesana, S; Re, F; Bezuidenhout, C; Bracco, S; Fernandez-Tejada, A; Anguita, J; Peri, F
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies
2024 Franco, A; Sadones, O; Romerio, A; Artusa, V; Shaik, M; Pasco, S; Italia, A; D'Amato, S; Anguita, J; Huebner, J; Romero-Saavedra, F; Peri, F
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases
2024 Italia, A; Franco, A; Shaik, M; Romerio, A; Lami, F; Lovisa, S; Peri, F; Costa, B
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists
2024 Ami, D; Franco, A; Artusa, V; Romerio, A; Shaik, M; Italia, A; Anguita, J; Pasco, S; Mereghetti, P; Peri, F; Natalello, A
Cleaner synthesis of preclinically validated vaccine adjuvants
2023 Romerio, A; Peri, F
Impact of Toll-like Receptor 4 (TLR4) chemical modulation by small- molecular antagonists in rare inflammatory-fibrotic diseases
2023 Italia, A; A Franco, A; Romerio, A; Shaik, M; Costa, B; Peri, F; Lovisa, S
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
2023 Romerio, A; Gotri, N; Franco, A; Artusa, V; Shaik, M; Pasco, S; Atxabal, U; Matamoros-Recio, A; Minguez-Toral, M; Zalamea, J; Franconetti, A; Abrescia, N; Jimenez-Barbero, J; Anguita, J; Martin-Santamaria, S; Peri, F
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity
2023 Romerio, A; Franco, A; Shadrick, M; Shaik, M; Artusa, V; Italia, A; Lami, F; Demchenko, A; Peri, F
Potentiation of fluoroquinolone and macrolide activities by efflux pump inhibitory effect on Staphylococcus aureus and Streptococcus pyogenes of new benzyl piperazinyl lysine derivatives
2023 Musumeci, R; Martinelli, M; Giubbi, C; Perdoni, F; Romerio, A; Vertemara, J; De Gioia, L; Peri, F; Cocuzza, C
Synthesis and Biological Characterization of TLR4 Agonists as Innovative Vaccine Adjuvants
2023 Romerio, A
Highly Selective SERCA2a Activators: Preclinical Development of a Congeneric Group of First-in-Class Drug Leads against Heart Failure
2022 Luraghi, A; Ferrandi, M; Barassi, P; Arici, M; Hsu, S; Torre, E; Ronchi, C; Romerio, A; Chang, G; Ferrari, P; Bianchi, G; Zaza, A; Rocchetti, M; Peri, F
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR
2021 Peri, F; Romerio, A; D'Amato, S
Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and in Vivo Activity
2021 Facchini, F; Minotti, A; Luraghi, A; Romerio, A; Gotri, N; Matamoros-Recio, A; Iannucci, A; Palmer, C; Wang, G; Ingram, R; Martin-Santamaria, S; Pirianov, G; De Andrea, M; Valvano, M; Peri, F
Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
2020 Romerio, A; Peri, F